Yoshitaka Hippo

19PUBLICATIONS
42CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 19, 2026
PhiKan 083 Inhibits MYCN Expression in Liver Cancer Cells Independent of p53 Pathways.

|Feb 18, 2026
Oncogenic function and transcriptional dynamics of MYCN in liver tumorigenesis.

Xian-Yang Qin, Yali Xu, Hricha Mishra

|Jan 21, 2026
Chemical Screening of RIKEN Natural Products Depository Identified a MYCN Expression Inhibitor Partially through HGF-MET Signaling Pathway.

Yali Xu, Hricha Mishra, Hiroyuki Osada

|Jul 19, 2025
Discovery of pyroptosis-inducing natural products in neuroblastomas: computational studies with experimental validation.

Beni Lestari, Rohmad Yudi Utomo, Faaza Aulia Rahman

|Dec 04, 2024
The Combination of Sorafenib and PGV-1 Inhibits the Proliferation of Hepatocellular Carcinoma Through c-Myc Suppression in an Additive Manner: In Vitro Studies.

Dhania Novitasari, Ikuko Nakamae, Noriko Yoneda-Kato

|Nov 04, 2024
PGV-1 Causes Disarrangement of Spindle Microtubule Organization Resulting in Aberrant Mitosis in HLF and HuH6 Cells Associated with Altered MYCN Status.

Nadzifa Nugraheni, Ummi Maryam Zulfin, Beni Lestari

Pageof 4

Frequent Collaborators

4 joint publications

Yoshiaki Maru

3 joint publications

Yusuke Suenaga

3 joint publications

Xian-Yang Qin

3 joint publications

Edy Meiyanto